{{Rsnum
|rsid=8077696
|Gene=RGS9
|Chromosome=17
|position=65196443
|Orientation=plus
|GMAF=0.2534
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=RGS9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 15.0 | 85.0
| HCB | 14.0 | 43.4 | 42.6
| JPT | 9.8 | 37.5 | 52.7
| YRI | 20.4 | 50.3 | 29.3
| ASW | 14.0 | 38.6 | 47.4
| CHB | 14.0 | 43.4 | 42.6
| CHD | 8.3 | 48.1 | 43.5
| GIH | 2.0 | 20.2 | 77.8
| LWK | 13.6 | 51.8 | 34.5
| MEX | 17.2 | 39.7 | 43.1
| MKK | 11.0 | 42.9 | 46.1
| TSI | 0.0 | 10.8 | 89.2
| HapMapRevision=28
}}
{{PMID Auto
|PMID=18548510
|Title=Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}